Niyam v2 is live — start for just ₹100 — 200 credits to try

march 2026

Delhi High Court · 2026-03-28

SUN PHARMA LABORATORIES LIMITED vs INTAS PHARMACEUTICALS LIMITED

Citation / case number
CS(COMM)-39/2023 2026:DHC:2601
Court
Delhi High Court
Petitioner
SUN PHARMA LABORATORIES LIMITED
Respondent
INTAS PHARMACEUTICALS LIMITED
Search all judgments

Judgment text excerpt

* IN THE HIGH COURT OF DELHI AT NEW DELHI % Judgment delivered on: 28.03.2026 CS(COMM) 39/2023 SUN PHARMA LABORATORIES LIMITED .....Plaintiff versus INTAS PHARMACEUTICALS LIMITED .....Defendant Advocates who appeared in this case For the Plaintiff : Mr. Sachin Gupta, Ms. Mahima Chanchalani, Ms. Prashansa, Mr. Rohit Pradhan, Ms. Diksha, Mr. Ajay & Mr. Aadarsh, Advocates. For the Defendant : Ms. Bitika Sharma, Mr. George Vithayathil, Ms. Ahaana Singh Rana & Mr. Aditya P. Mishra, Advocates. CORAM: HON'BLE MR. JUSTICE TEJAS KARIA JUDGMENT TEJAS KARIA, J 1. The present Suit has been filed seeking a permanent injunction against infringement of the Trade Mark ‘BEVETEX’ (“Plaintiff’s Mark”), passing off, unfair competition, dilution, rendition of accounts and damages. 2. The drug under the Plaintiff’s Mark (“Plaintiff’s Drug”) is a scheduled drug used for treatment of breast cancer, non-small cell lung cancer and pancreatic cancer. The Defendant is using the Mark ‘BEVATAS’ 3. The present Suit was listed before the Court of the District Judge, Saket Courts, Delhi (“Trial Court”) on 02.01.2018, wherein the learned Trial Court refused to grant an ex-parte ad-interim injunction on the ground t